Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CAPR OTCMKTS:INBP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAPRCapricor Therapeutics$33.94-1.3%$31.45$4.30▼$40.37$1.99B0.48936,525 shs666,035 shsINBPIntegrated BioPharma$0.25-1.0%$0.28$0.21▼$0.42$7.74M0.419,903 shs10,505 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAPRCapricor Therapeutics-1.28%+1.07%+6.16%+37.30%+393.67%INBPIntegrated BioPharma0.00%+6.38%-13.37%-26.14%-13.79%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAPRCapricor Therapeutics$33.94-1.3%$31.45$4.30▼$40.37$1.99B0.48936,525 shs666,035 shsINBPIntegrated BioPharma$0.25-1.0%$0.28$0.21▼$0.42$7.74M0.419,903 shs10,505 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAPRCapricor Therapeutics-1.28%+1.07%+6.16%+37.30%+393.67%INBPIntegrated BioPharma0.00%+6.38%-13.37%-26.14%-13.79%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCAPRCapricor Therapeutics 2.80Moderate Buy$46.0935.80% UpsideINBPIntegrated BioPharma 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CAPR and INBP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/13/2026CAPRCapricor Therapeutics Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOverweight$62.003/13/2026CAPRCapricor Therapeutics B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$50.00 ➝ $63.003/13/2026CAPRCapricor Therapeutics Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$45.00 ➝ $58.003/10/2026CAPRCapricor Therapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$60.00(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCAPRCapricor Therapeutics$22.27M88.15N/AN/A$5.53 per share6.14INBPIntegrated BioPharma$54.35M0.14$0.07 per share3.73$0.66 per share0.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCAPRCapricor Therapeutics-$105.04M-$2.26N/AN/AN/AN/A-67.52%-54.59%5/12/2026 (Estimated)INBPIntegrated BioPharma$810K-$0.02N/AN/AN/A-0.40%-1.02%-0.83%5/12/2026 (Estimated)Latest CAPR and INBP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026CAPRCapricor Therapeutics-$0.55N/AN/AN/A$40.00 millionN/A3/12/2026Q4 2025CAPRCapricor Therapeutics-$0.51-$0.62-$0.11-$0.62$0.53 millionN/A2/11/2026Q2 2026INBPIntegrated BioPharmaN/A-$0.03N/A-$0.03N/A$11.28 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCAPRCapricor TherapeuticsN/AN/AN/AN/AN/AINBPIntegrated BioPharmaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCAPRCapricor TherapeuticsN/A9.019.01INBPIntegrated BioPharmaN/A5.032.67Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCAPRCapricor Therapeutics21.68%INBPIntegrated BioPharma25.25%Insider OwnershipCompanyInsider OwnershipCAPRCapricor Therapeutics9.20%INBPIntegrated BioPharma67.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCAPRCapricor Therapeutics10157.84 million52.52 millionOptionableINBPIntegrated BioPharma15030.98 million10.10 millionNot OptionableCAPR and INBP HeadlinesRecent News About These CompaniesIntegrated BioPharma, Inc.: Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025February 11, 2026 | finanznachrichten.deIntegrated BioPharma Reports Results for Its Quarter Ended December 31, 2025February 11, 2026 | accessnewswire.comAIntegrated BioPharma Holds 2025 Annual Stockholder MeetingDecember 10, 2025 | theglobeandmail.comRentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutionsDecember 2, 2025 | globenewswire.comIntegrated BioPharma Reports Results for Its Quarter Ended September 30, 2025November 10, 2025 | accessnewswire.comAIntegrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025September 23, 2025 | accessnewswire.comAINBP Integrated BioPharma, Inc.June 15, 2025 | seekingalpha.comIntegrated BioPharma Reports Results for its Quarter Ended March 31, 2025May 14, 2025 | accessnewswire.comAIntegrated BioPharma Secures New Credit Line with PNCApril 21, 2025 | tipranks.comIntegrated BioPharma Reports Results for its Quarter Ended December 31, 2024February 13, 2025 | accessnewswire.comAIntegrated BioPharma Reports Results for its Quarter Ended September 30, 2024November 13, 2024 | accesswire.comAIntegrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024September 20, 2024 | accesswire.comAAbbott partners with maker of ‘bionic pancreas’September 5, 2024 | medtechdive.comMIntegrated Biopharma Inc (INBP)August 31, 2024 | investing.comShanghai unveils US$13.7 billion capital injection into IC, AI, and biopharma industriesAugust 1, 2024 | digitimes.comDIntegrated BioPharma, Inc. (INBP)July 19, 2024 | finance.yahoo.comIntegrated BioPharma Reports Results for its Quarter Ended March 31, 2024May 10, 2024 | accesswire.comAIntegrated nanoelectronics for the futureFebruary 19, 2024 | nature.comNIntegrated BioPharma Reports Results for its Quarter Ended December 31, 2023February 12, 2024 | finance.yahoo.comHow to buy the best integrated washing machineFebruary 2, 2024 | which.co.ukWNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCAPR and INBP Company DescriptionsCapricor Therapeutics NASDAQ:CAPR$33.94 -0.44 (-1.28%) Closing price 05/7/2026 04:00 PM EasternExtended Trading$29.48 -4.47 (-13.16%) As of 05/7/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Capricor Therapeutics, Inc. (NASDAQ:CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. Capricor's lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy. Capricor has also established itself as one of the leading companies investigating the field of extracellular vesicles and is exploring the potential of CAP-2003, a cell-free, exosome-based candidate, to treat a variety of disorders. Integrated BioPharma OTCMKTS:INBP$0.25 0.00 (-0.99%) As of 05/7/2026 11:30 AM EasternIntegrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally IonQ Just Posted a Breakout Quarter—But 1 Problem Remains Super Micro Surges Over 20% as Margins Soar, Sales Fall Short Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised Anheuser-Busch Stock Jumps as Volume Growth Signals Turnaround Light Speed Returns: Corning Cashes In on NVIDIA Growth Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
